December Issue

Issue:

December 2012

Former FDA Commissioner Admits Risk of Bureaucratic Delay

Medical innovation has been suffocated by the FDA’s flawed drug approval process. An increasing number of scholarly individuals recognize that delaying lifesaving therapies can no longer be tolerated, including former FDA Commissioner Andrew von Eschenbach.

Reports
Departments
Recent Issues
Magazine Archives

Subscribe to Life Extension Magazine®

Subscribe Now

Advertise in Life Extension Magazine®

Learn More